LAB STANDARD BIOTOOLS INC.

8-K Current Report

Filed: February 24, 2026

Health Care

Laboratory Analytical Instruments

STANDARD BIOTOOLS INC. (LAB) 8-K current report filed with SEC EDGAR on February 24, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
2 items

Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Q4/full-year 2025 earnings release filed February 24, 2026, signed by CFO Alex Kim
• No financial figures included in 8-K body — refer to attached press release exhibit for actual results

Item 7.01 · Regulation FD Disclosure

• Full year 2026 revenue outlook disclosed via Reg FD — specific guidance figures contained in the referenced exhibit
• Reg FD disclosure ensures simultaneous public access to forward-looking revenue guidance material to valuation

+1 more insights

Get deeper insights on STANDARD BIOTOOLS INC.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.